NLRP3 and metabolic syndrome: Overexpression of NLRP3 leading to elevated proinflammatory cytokines IL-1β and IL-18, followed by inflammatory cell infiltration in the glomerulus, was discovered in a study of diabetic nephropathy rats regarding hyperuricemia and dyslipidemia [56].